Cyprotex is a contract research organisation that helps to identify the most prospective drug compounds. The company specialises in Absorption, Distribution, Metabolism, Excretion / Toxicity data for drug compounds. Cyprotex joined Aim on 15 February 2002. It raised 5.5m net at 29p a share, which valued the company at 26.2m.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds